Carregant...
Outcome measures and treatment effectiveness in late onset myasthenia gravis
BACKGROUND: Recently different subtypes of myasthenia gravis (MG) have been described. They differ for clinical features and pathogenesis but the prognosis and response to treatment is less clear. The aim of the study was to evaluate outcome and treatment effectiveness including side effects in late...
Guardat en:
| Publicat a: | Neurol Res Pract |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7650071/ https://ncbi.nlm.nih.gov/pubmed/33324944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s42466-020-00091-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|